表紙
市場調查報告書

羊膜穿刺針的全球市場:2019年∼2023年

Global Amniocentesis Needle Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 793674
出版日期 內容資訊 英文 130 Pages
訂單完成後即時交付
價格
羊膜穿刺針的全球市場:2019年∼2023年 Global Amniocentesis Needle Market 2019-2023
出版日期: 2019年02月18日內容資訊: 英文 130 Pages
簡介

接受羊膜穿刺術為孕婦及其家人提供了特定的機會。羊膜穿刺術以非常高的準確度產生遺傳測試結果。它可以檢測孕婦的神經管缺陷和腹壁缺陷。羊膜穿刺術是使用羊水的唯一檢驗,含有胎兒的細胞和蛋白質。胎兒存在先天性疾病的情況下,父母可以選擇終止(墮胎)或決定繼續妊娠。羊膜穿刺術和CVS可以可靠地檢測出嚴重的遺傳異常,而產前篩查和產前基因檢測無法檢測到這些遺傳異常。這是一個主要優勢,因為如果結果證明是肯定的,可以儘早開始護理和治療。因此,對羊膜穿刺術產前診斷的需求日益增加,從而推動市場成長。Technavio的分析師預測,到2023年,羊膜穿刺針市場的年複合成長率將接近4%。

本報告提供全球羊膜穿刺針市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 報告的範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各應用領域

  • 市場區隔:各應用領域
  • 各應用領域比較:市場規模及預測(2018年∼2023年)
  • 羊膜穿刺
  • 胎兒輸血
  • 羊水消除
  • 其他
  • 市場機會:各應用領域

第7章 客戶形勢

第8章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 比較:各終端用戶市場規模及預測(2018年∼2023年)
  • 醫院
  • 診斷研究所
  • 其他
  • 市場機會:各終端用戶

第9章 地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭模式

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • BD
  • Cardinal Health
  • Integra LifeSciences
  • Medline Industries, Inc.
  • Smiths Group plc
  • The Cooper Companies, Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
目錄
Product Code: IRTNTR30878

About this market

Undergoing the amniocentesis procedure provides certain opportunities to both the expectant mother and her families. Amniocentesis yields genetic test results with very high accuracy. It can detect neural tube defects and abdominal wall defects in a pregnant woman. Amniocentesis is the only test Mere amino fluid is taken for testing, which contains the fetus' cells and proteins. In the presence of congenital disorder in the fetus, the parent can opt for termination (abortion) or decide to carry on with the pregnancy. Amniocentesis and CVS can reliably detect serious genetic abnormalities, which otherwise remain undetected with prenatal screening and prenatal genetic testing. This is a major advantage as care and treatment can be started early if results prove positive. Hence, there is an increasing demand for the amniocentesis procedure for prenatal diagnosis, thereby driving market growth. Technavio's analysts have predicted that the amniocentesis needle market will register a CAGR of almost 4% by 2023.

Market Overview

Increase in pregnancy rate

The teen birth rate in the US is higher than that in many other developed countries such as Canada and the UK. Thus, the increase in pregnancy rates will indirectly result in the rise of prenatal diagnosis through procedures such as amniocentesis, thereby driving the global amniocentesis needle market.

Lack of awareness of amniocentesis technique

The popularity of prenatal diagnosis and its efficacy in detecting genetic disorders depends, to a large extent, on the awareness and acceptability of available methods. The lack of awareness of the amniocentesis procedure can lead to marginal demand for this technique, thereby restricting market growth.

For the detailed list of factors that will drive and challenge the growth of the amniocentesis needle market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

  • Market segmentation by application
  • Comparison by application
  • Amniocentesis - Market size and forecast 2018-2023
  • Fetal blood transfusion - Market size and forecast 2018-2023
  • Amnioreduction - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals - Market size and forecast 2018-2023
  • Diagnostic laboratories - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • BD
  • Cardinal Health
  • Integra LifeSciences
  • Medline Industries, Inc.
  • Smiths Group plc
  • The Cooper Companies, Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global medical devices market
  • Exhibit 02: Segments of global medical devices market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Application - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by application
  • Exhibit 19: Amniocentesis - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Amniocentesis - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Fetal blood transfusion - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Fetal blood transfusion - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Amnioreduction - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Amnioreduction - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 26: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 27: Market opportunity by application
  • Exhibit 28: Customer landscape
  • Exhibit 29: End-user - Market share 2018-2023 (%)
  • Exhibit 30: Comparison by end-user
  • Exhibit 31: Hospitals - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Hospitals - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Diagnostic laboratories - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Diagnostic laboratories - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Market opportunity by end-user
  • Exhibit 38: Market share by geography 2018-2023 (%)
  • Exhibit 39: Geographic comparison
  • Exhibit 40: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 41: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 42: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 43: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 44: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 45: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 46: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 47: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 48: Key leading countries
  • Exhibit 49: Market opportunity
  • Exhibit 50: Impact of drivers and challenges
  • Exhibit 51: Vendor landscape
  • Exhibit 52: Landscape disruption
  • Exhibit 53: Vendors covered
  • Exhibit 54: Vendor classification
  • Exhibit 55: Market positioning of vendors
  • Exhibit 56: BD - Vendor overview
  • Exhibit 57: BD - Business segments
  • Exhibit 58: BD - Organizational developments
  • Exhibit 59: BD - Geographic focus
  • Exhibit 60: BD - Segment focus
  • Exhibit 61: BD - Key offerings
  • Exhibit 62: Cardinal Health - Vendor overview
  • Exhibit 63: Cardinal Health - Business segments
  • Exhibit 64: Cardinal Health - Organizational developments
  • Exhibit 65: Cardinal Health - Geographic focus
  • Exhibit 66: Cardinal Health - Segment focus
  • Exhibit 67: Cardinal Health - Key offerings
  • Exhibit 68: Integra LifeSciences - Vendor overview
  • Exhibit 69: Integra LifeSciences - Business segments
  • Exhibit 70: Integra LifeSciences - Geographic focus
  • Exhibit 71: Integra LifeSciences - Segment focus
  • Exhibit 72: Integra LifeSciences - Key offerings
  • Exhibit 73: Medline Industries, Inc. - Vendor overview
  • Exhibit 74: Medline Industries, Inc. - Key offerings
  • Exhibit 75: Smiths Group plc - Vendor overview
  • Exhibit 76: Smiths Group plc - Business segments
  • Exhibit 77: Smiths Group plc - Organizational developments
  • Exhibit 78: Smiths Group plc - Geographic focus
  • Exhibit 79: Smiths Group plc - Segment focus
  • Exhibit 80: Smiths Group plc - Key offerings
  • Exhibit 81: The Cooper Companies, Inc. - Vendor overview
  • Exhibit 82: The Cooper Companies, Inc. - Business segments
  • Exhibit 83: The Cooper Companies, Inc. - Organizational developments
  • Exhibit 84: The Cooper Companies, Inc. - Geographic focus
  • Exhibit 85: The Cooper Companies, Inc. - Segment focus
  • Exhibit 86: The Cooper Companies, Inc. - Key offerings
  • Exhibit 87: Validation techniques employed for market sizing